Reccurent thrombus in the gigantic left atrium during effective anticoagulant therapy: case report.
Aged
Clopidogrel
/ administration & dosage
Drug Therapy, Combination
Factor Xa Inhibitors
/ administration & dosage
Heart Atria
/ diagnostic imaging
Heart Diseases
/ diagnostic imaging
Heart Valve Prosthesis Implantation
/ adverse effects
Humans
Male
Mitral Valve Annuloplasty
/ adverse effects
Mitral Valve Insufficiency
/ diagnostic imaging
Platelet Aggregation Inhibitors
/ administration & dosage
Recurrence
Rivaroxaban
/ administration & dosage
Thrombectomy
Thrombosis
/ diagnostic imaging
Treatment Outcome
Anticoagulant therapy
Atrial fibrillation
Cardiac magnetic resonance
Echocardiography
Gigantic left atrium
Recurrent thrombus
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
21 02 2020
21 02 2020
Historique:
received:
24
01
2019
accepted:
26
11
2019
entrez:
23
2
2020
pubmed:
23
2
2020
medline:
30
9
2020
Statut:
epublish
Résumé
Gigantic left atrium is defined in the current literature as an excessive dilatation of the left atrium above 65mm. Chronic mitral valve disease is associated with the development of thrombus in the left atrium in up to 19% of all cases of mitral insufficiency and appropriate treatment must be initiated to prevent thromboembolic events. In order to diagnose thrombi in the left atrium or left atrial appendage, various imaging methods may be used, including cardiac magnetic resonance. The case report describes a 73-year-old male who developed recurrent sessile thrombus on the posterior wall of the gigantic left atrium. A large thrombus was first detected following mitral valve surgery despite effective vitamin K antagonist anticoagulation therapy. Echocardiography and cardiac magnetic resonance were used within the diagnostic procedure and to monitor the treatment outcomes. Cardiac magnetic resonance was shown to be beneficial as it provided a more precise description of the intra-atrial masses located on the posterior left atrial wall, and in such situations, is of greater benefit than standard echocardiography. This led to the surgical removal of the intra-atrial mass; nevertheless, it was quickly followed by the recurrence of the thrombus. The anticoagulant therapy was adjusted and fortified by the introduction of acetylsalicylic acid and sequentially clopidogrel, but this also did not resolve the thrombus formation. Finally, employing a combination of rivaroxaban and clopidogrel resulted in partial thrombus regression. Therefore, various pathophysiological aspects of thrombus formation and used anticoagulation strategies are discussed. We describe a unique case of a recurrent thrombus located on the posterior wall of the gigantic left atrium. Cardiac magnetic resonance was shown to be beneficial in providing a more precise description of the intra-atrial masses located on the posterior left atrial wall as compared to standard echocardiographic examination. Development of a thrombus after mitral valve surgery despite effective anticoagulant therapy and its final resolution by introducing a combination of rivaroxaban and clopidogrel highlights the complex etiopathogenesis of thrombus formation. This supports the potential use of this combination in tailoring an individual personalized therapy for patients with recurrent atrial thrombi.
Sections du résumé
BACKGROUND
Gigantic left atrium is defined in the current literature as an excessive dilatation of the left atrium above 65mm. Chronic mitral valve disease is associated with the development of thrombus in the left atrium in up to 19% of all cases of mitral insufficiency and appropriate treatment must be initiated to prevent thromboembolic events. In order to diagnose thrombi in the left atrium or left atrial appendage, various imaging methods may be used, including cardiac magnetic resonance.
CASE PRESENTATION
The case report describes a 73-year-old male who developed recurrent sessile thrombus on the posterior wall of the gigantic left atrium. A large thrombus was first detected following mitral valve surgery despite effective vitamin K antagonist anticoagulation therapy. Echocardiography and cardiac magnetic resonance were used within the diagnostic procedure and to monitor the treatment outcomes. Cardiac magnetic resonance was shown to be beneficial as it provided a more precise description of the intra-atrial masses located on the posterior left atrial wall, and in such situations, is of greater benefit than standard echocardiography. This led to the surgical removal of the intra-atrial mass; nevertheless, it was quickly followed by the recurrence of the thrombus. The anticoagulant therapy was adjusted and fortified by the introduction of acetylsalicylic acid and sequentially clopidogrel, but this also did not resolve the thrombus formation. Finally, employing a combination of rivaroxaban and clopidogrel resulted in partial thrombus regression. Therefore, various pathophysiological aspects of thrombus formation and used anticoagulation strategies are discussed.
CONCLUSIONS
We describe a unique case of a recurrent thrombus located on the posterior wall of the gigantic left atrium. Cardiac magnetic resonance was shown to be beneficial in providing a more precise description of the intra-atrial masses located on the posterior left atrial wall as compared to standard echocardiographic examination. Development of a thrombus after mitral valve surgery despite effective anticoagulant therapy and its final resolution by introducing a combination of rivaroxaban and clopidogrel highlights the complex etiopathogenesis of thrombus formation. This supports the potential use of this combination in tailoring an individual personalized therapy for patients with recurrent atrial thrombi.
Identifiants
pubmed: 32085730
doi: 10.1186/s12872-019-01279-1
pii: 10.1186/s12872-019-01279-1
pmc: PMC7035782
doi:
Substances chimiques
Factor Xa Inhibitors
0
Platelet Aggregation Inhibitors
0
Rivaroxaban
9NDF7JZ4M3
Clopidogrel
A74586SNO7
Types de publication
Case Reports
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
86Subventions
Organisme : Ministerstvo Školství, Mládeže a Tělovýchovy (CZ)
ID : LQ1605 - National Program of Sustainability II (MEYS CR)
Pays : International
Références
J Thromb Thrombolysis. 2017 Feb;43(2):139-148
pubmed: 27614756
Ann Intern Med. 2004 Jan 20;140(2):101-5
pubmed: 14734332
Korean Circ J. 2016 Nov;46(6):875-878
pubmed: 27826350
Eur J Echocardiogr. 2001 Dec;2(4):270-6
pubmed: 11888821
Herz. 2019 Aug;44(5):390-397
pubmed: 29374292
Cardiovasc Ultrasound. 2016 Jan 05;14:2
pubmed: 26729298
Circulation. 1990 Sep;82(3):792-7
pubmed: 2144217
Ann Surg. 1971 Aug;174(2):194-201
pubmed: 4254395
Circ Cardiovasc Imaging. 2012 Sep 1;5(5):667-75
pubmed: 22767653
J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1747-9
pubmed: 24725815
J Cardiovasc Surg (Torino). 1984 Jul-Aug;25(4):328-36
pubmed: 6237112
J Cardiol. 2001 Jun;37(6):325-33
pubmed: 11433808
Cardiology. 2010;117(3):219-21
pubmed: 21196730
Ann Thorac Surg. 2016 Nov;102(5):e461
pubmed: 27772610
Tex Heart Inst J. 2006;33(3):389-91
pubmed: 17041705
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):177-94
pubmed: 26162958
Ann Card Anaesth. 2018 Jan-Mar;21(1):97-98
pubmed: 29336407
J Med Case Rep. 2017 Apr 9;11(1):97
pubmed: 28390428